🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11375+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11375 recruiting trials

Phase 2RecruitingNCT06752798

Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC

🏥 Hunan Cancer Hospital📍 1 site📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06734871

A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma

👨‍⚕️ Aibin Liang MD,Ph.D., Shanghai Tongji Hospital, Tongji University School of Medicine📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06730672

An Exploratory Study on the Failure of Immunotherapy With Voronib Combined With Everolimus

👨‍⚕️ Fangjian F Zhou, M.D, 中山大学肿瘤防治中心📍 2 sites📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06751134

Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma

🏥 Nanjing Children's Hospital📍 2 sites📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06566079

Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors

🏥 InSilico Medicine Hong Kong Limited📍 10 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06446154

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

🏥 Sun Yat-sen University📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06752096

Robot-Assisted Neurovascular Intervention

🏥 Navigantis Inc.📍 1 site📅 Started Dec 2024View details ↗
Phase 3RecruitingNCT06743646

Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

👨‍⚕️ Jinlu Zhang, MD, Chigenovo Co., Ltd📍 8 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06650514

A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma

🏥 Vall d'Hebron Institute of Oncology📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06390319

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

👨‍⚕️ Seth E. Karol, MD, MSCI, St. Jude Children's Research Hospital📍 3 sites📅 Started Dec 2024View details ↗
Phase 4RecruitingNCT06289673

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

👨‍⚕️ Seth E. Karol, MD, St. Jude Children's Research Hospital📍 3 sites📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06756490

A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation

🏥 Sichuan Huiyu Pharmaceutical Co., Ltd📍 2 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06794008

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

👨‍⚕️ Zhanguo Li, Peking University Institute of Rheuamotology and Immunology📍 1 site📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06432036

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

👨‍⚕️ Siddharth A Padia, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT07195500

Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma

👨‍⚕️ Guoqiang Shao, Dr, Nanjing First Hospital, Nanjing Medical University📍 1 site📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06746519

BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia

🏥 Chen Suning📍 1 site📅 Started Dec 2024View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT06764329

The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.

🏥 National Institute of Blood and Marrow Transplant (NIBMT), Pakistan📍 2 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06716658

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 2 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06987552

Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients

👨‍⚕️ Shih-Chieh Chueh, National Taiwan University Hospital📍 1 site📅 Started Dec 2024View details ↗
NAEnrolling by InvitationNCT06924515

The Application Value of Intercostal Suturing in Preventing Postoperative Thoracoscopic Lung Resection Chest Wall Pulmonary Hernia

🏥 Mingjian Ge📍 1 site📅 Started Dec 2024View details ↗
← PreviousPage 184 of 569Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →